Serum miR-30c-5p is a potential biomarker for multiple system atrophy

[1]  M. J. Simard,et al.  A guide to microRNA‐mediated gene silencing , 2018, The FEBS journal.

[2]  Linyin Feng,et al.  Nuclear Accumulation of Histone Deacetylase 4 (HDAC4) Exerts Neurotoxicity in Models of Parkinson’s Disease , 2017, Molecular Neurobiology.

[3]  T. Masaki,et al.  Serum microRNA expression profiling in patients with multiple system atrophy , 2017, Journal of the Neurological Sciences.

[4]  Jeong-Sun Kim,et al.  Parkin mediates neuroprotection through activation of Notch1 signaling , 2017, Neuroreport.

[5]  C. Pichon,et al.  MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments? , 2017, Current Neuropharmacology.

[6]  Ilona B. Bruinsma,et al.  MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy , 2016, Molecular Neurobiology.

[7]  L. Alberi,et al.  Notch1 hallmarks fibrillary depositions in sporadic Alzheimer’s disease , 2016, Acta Neuropathologica Communications.

[8]  C. Wahlestedt,et al.  Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson’s Disease , 2016, Journal of Parkinson's disease.

[9]  Z. Qin,et al.  A pivotal role of FOS-mediated BECN1/Beclin 1 upregulation in dopamine D2 and D3 receptor agonist-induced autophagy activation , 2015, Autophagy.

[10]  R. Freeman,et al.  Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative , 2015, Neurobiology of Disease.

[11]  A. Christoffels,et al.  Evidence for a common biological pathway linking three Parkinson's disease‐causing genes: parkin, PINK1 and DJ‐1 , 2015, The European journal of neuroscience.

[12]  D. Galimberti,et al.  Profiling of Ubiquitination Pathway Genes in Peripheral Cells from Patients with Frontotemporal Dementia due to C9ORF72 and GRN Mutations , 2015, International journal of molecular sciences.

[13]  A. Antonini,et al.  Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy , 2014, Front. Cell. Neurosci..

[14]  M. Denti,et al.  Circulating miRNAs as Biomarkers for Neurodegenerative Disorders , 2014, Molecules.

[15]  V. Choubey,et al.  BECN1 is involved in the initiation of mitophagy , 2014, Autophagy.

[16]  V. Álvarez,et al.  Profile of microRNAs in the plasma of Parkinson’s disease patients and healthy controls , 2013, Journal of Neurology.

[17]  J. Son,et al.  Neuronal autophagy and neurodegenerative diseases , 2012, Experimental & Molecular Medicine.

[18]  A. Kanthasamy,et al.  Paraquat induces epigenetic changes by promoting histone acetylation in cell culture models of dopaminergic degeneration. , 2011, Neurotoxicology.

[19]  E. Masliah,et al.  α-Synuclein Sequesters Dnmt1 from the Nucleus , 2011, The Journal of Biological Chemistry.

[20]  A. Gulino,et al.  MicroRNAs as biomarkers for CNS cancer and other disorders , 2010, Brain Research.

[21]  M. Russo,et al.  The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy , 2010, Cell Death and Differentiation.

[22]  Brian Spencer,et al.  The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. , 2008, The Journal of clinical investigation.

[23]  J. Jankovic,et al.  Parkinson's Disease & Movement Disorders , 2002 .

[24]  J. Trojanowski,et al.  Synucleinopathies: clinical and pathological implications. , 2001, Archives of neurology.

[25]  N P Quinn,et al.  Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. , 1994, Brain : a journal of neurology.

[26]  S. Khoo,et al.  Plasma-based circulating MicroRNA biomarkers for Parkinson's disease. , 2012, Journal of Parkinson's disease.